Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Strength: 330mg
Macsay explains
The SELECT trial builds on these results, showing that once-weekly semaglutide resulted in a 20% reduction in the primary composite endpoint of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with pre-existing cardiovascular disease and BMI 27kg/m 2
This finding, in addition to the observation that PK profiles of S- and R-warfarin are unaffected, supports the absence of a drugdrug interaction between semaglutide and warfarin
FRI359 Postprandial hypoglycemia with elevated pro-insulin as A rare presentation of insulinoma
analyzed the lipid profile and aquaporin expression under conditions of oxidative stress in different types of breast cancer cells and predicted the subsequent metabolic reprogramming of cancer cells and adaption to stress and resistance to therapies [68]
US$ 25.53
US$ 27.39
US$ 21.94
US$ 21.76
